Restructuring |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring | Restructuring Restructuring of our China Operations In May 2017, the Company announced it would no longer continue to serve the domestic market in China and would refocus its China operations entirely on the export business. For the nine months ended September 30, 2017, we recognized $3.3 million in restructuring charges as detailed below:
For the nine months ended September 30, 2017, $2.5 million was included in Other Cost of Revenue, $0.7 million in Sales and Operations expenses, and $0.1 million was included in General and Administrative expenses. No additional charges related to restructuring were recorded in the three months ended September 30, 2017. As of December 31, 2017, we had a restructuring liability of $0.4 million included in other current liabilities on the consolidated statement of financial position. No additional expenses were recorded related to this restructuring in the nine months ended September 30, 2018 and the remaining $0.4 million was paid during the period resulting in the extinguishment of the restructuring liability as of September 30, 2018. Discontinuation of Criteo Predictive Search On October 31, 2017, the Company announced that it had decided to discontinue the Criteo Predictive Search product. $4.1 million was recognized as restructuring charges in 2017. For the nine months ended September 30, 2018, we recognized a gain of $0.1 million. This gain was due to employees being relocated within the company rather than being terminated and a reduction of share-based compensation expenses which was partially offset by additional charges for facilities and employee severance agreements.
For the nine months ended September 30, 2018, $0.2 million was included in Sales and Operations expenses and $(0.3) million in Research and Development expenses. Other costs relate to a reduction of share-based compensation expenses of $(0.5) million due to forfeitures. No additional charges related to restructuring were recorded in the three months ended September 30, 2018. The following table summarizes restructuring activities as of September 30, 2018 included in other current liabilities on the balance sheet:
|